Retreatment with direct-acting antivirals of genotypes 1-3-4 hepatitis C patients who failed an anti-NS5A regimen in real world

J Hepatol. 2018 Mar;68(3):595-597. doi: 10.1016/j.jhep.2017.09.019. Epub 2017 Oct 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents* / classification
  • Antiviral Agents* / pharmacology
  • Drug Resistance, Viral
  • Hepacivirus* / drug effects
  • Hepacivirus* / genetics
  • Hepatitis C, Chronic* / drug therapy
  • Hepatitis C, Chronic* / virology
  • Humans
  • Retreatment / methods*
  • Treatment Outcome

Substances

  • Antiviral Agents